EXCLUSIVE: 60 Lawmakers Support Lawsuit to Limit Abortion Pill After Trump Requested Pause

Jesse Jackson, Civil Rights Leader, Dies at 84

EXPOSED: Taxpayers Paying for Democrat Activists’ Grad School Tuition

Plummeting Public Trust, Mass Layoffs: Is Legacy Media Becoming Irrelevant?

 PoliticsSocietyCommentary

Immigration Is Shaking Up Political Parties in Britain, Europe, and the US

EXCLUSIVE: Border Patrol Stops Large Human Smuggling Attempt in California  

Clinton-Appointed Judge Rules on Newsom-Backed Mask Ban for ICE

With Judge’s Ruling on TPS, Springfield Is Back in the News

Daughter Pleads for Father’s Release From Chinese Prison 

What to Expect in PLA Activities Near Taiwan Leading Up to Trump and Xi Summit

 InternationalCommentary

The Sensor Web That Could Shape the Indo-Pacific

 InternationalSecurityCommentary

What Maduro’s Capture Says About a Similar Raid by China on Taiwan

GOP Trolls Democrat Opposition to Voter ID When Elected Officials Need IDs to Vote in the House

DHS Shutdown Coincides With Senators’ Trip

Pro-Corn Congressmen Fight to Put E15 Fuel on Market

THUNE: DHS Shutdown Very Likely

Schumer Vows to Fight Supposed ‘Jim Crow 2.0’ Bill With Policy 83% of Americans Support

‘Want to Cheat’: Noem Rips ‘Conspiracy Theories’ Against SAVE America Act

Democrats to ‘Disenfranchise Voters’ With Election Integrity Opposition, GOP Says

What the FBI Confirmed About Georgia 2020 Vote Counting Before the Raid

‘War Was Visited Upon These People’: Play About Oct. 7 Comes to DC

Are Americans Being Radicalized Online and Converting to Islam?

International Analysis

Why Is the Iran Regime on the Verge of Collapse?

Trump Envoy Announces Next Phase of Gaza Peace Plan 

OH BABY! Couples Could Make Big Money on Trump Accounts

What Comes Next for Venezuela? State Department Official Explains

ICE Operations: What Americans Actually Want  

To End Minnesota Chaos, Cut Off the Funding

EXPOSED: Taxpayers Paying for Democrat Activists’ Grad School Tuition

Trump, Beware—These ‘Unforced Errors’ Could Hand Democrats a Midterm Win

China’s Quiet Infiltration of America

Rep. Balderson Discusses Ohio’s Key Role in Energy

EXCLUSIVE: 60 Lawmakers Support Lawsuit to Limit Abortion Pill After Trump Requested Pause

Sen. Bill Cassidy. (Chip Somodevilla/Getty Images)

Elizabeth Troutman Mitchell / @TheElizMitchell

Elizabeth Troutman Mitchell is the White House Correspondent for "The Daily Signal." Send her an email.

FIRST ON THE DAILY SIGNAL—A coalition of 60 lawmakers filed an amicus brief supporting a lawsuit to limit the abortion pill after the Trump administration requested a pause to the case, The Daily Signal can first report.

On Friday, 58 Republican representatives and senators, led by Senator Bill Cassidy of Louisiana and Rep. Chris Smith of New Jersey, filed the amicus brief in support of Louisiana’s effort to restore the in-person dispensing requirement on the abortion pill.

Louisiana Attorney General Liz Murrill filed a lawsuit in 2025 challenging a Biden-era rule allowing abortion drugs to be dispensed to women through the mail without seeing a doctor first. A hearing for State of Louisiana v. Food and Drug Administration is scheduled for Feb. 24.

Ahead of the hearing, President Donald Trump’s Department of Justice asked a federal court to pause Louisiana’s case against the Food and Drug Administration while the agency conducts a safety review into the abortion drug mifepristone.

“I thank Attorney General Murrill for defending women and babies in Louisiana and across the country. Chemical abortion drugs kill innocent children and put mothers’ lives at risk,” said Cassidy, who chairs the Senate Health, Education, Labor, and Pensions Committee. “Safeguards protecting against coercion, such as the in-person dispensing requirement, must be reinstated immediately.” 

‘Why Is It Taking So Long’? Senate Health Chair Urges Immediate FDA Action on Abortion PillThe Food and Drug Administration should “immediately” restore in-person dispensing requirements for the abortion pill, Sen. Bill Cassidy, R-La., told @TheElizMitchell. The senator… pic.twitter.com/F54LzanmJi— The Daily Signal (@DailySignal) January 14, 2026

‘Why Is It Taking So Long’? Senate Health Chair Urges Immediate FDA Action on Abortion PillThe Food and Drug Administration should “immediately” restore in-person dispensing requirements for the abortion pill, Sen. Bill Cassidy, R-La., told @TheElizMitchell. The senator… pic.twitter.com/F54LzanmJi

Louisiana filed the lawsuit alongside resident Rosalie Markezich, who says her boyfriend coerced her into taking abortion pills, which he ordered from a doctor in California. While Louisiana law prohibits abortions in almost all cases, the lack of an in-person dispensing requirement on the drugs allowed him to obtain the drugs out of state through the mail.

The GOP lawmakers argue that Biden violated federal law by removing the in-person dispensing requirement, and that these protections should be reinstated.

When Congress passed the Comstock Act, it declared that abortion drugs are “nonmailable matter” by the United States Postal Service and private carriers, but the Biden administration illegally allowed abortion pills to be shipped across the country, the brief states.

“This action contravenes federal laws passed by the elected representatives of the American people,” according to the brief. “It also contravenes state laws prohibiting abortion, such as Louisiana’s, even though ‘the authority to regulate abortion’ belongs to ‘the people and their elected representatives,’ not unelected bureaucrats.”

The Biden FDA also did not properly consider the safety risk of the abortion pill when removing the in-person dispensing requirement, according to the lawmakers.

A study from the Ethics and Public Policy Center found that 11% of women experience adverse health effects, such as sepsis, infection, hemorrhaging, within 45 days following a mifepristone abortion.

EXCLUSIVE??: @DrMakaryFDA responded to a report saying he is delaying the review of the abortion pill.The FDA is currently in the “data acquisition phase” of the review," he told @DailySignal.“We do an ongoing review, but we’re also engaging in a robust study that can serve… pic.twitter.com/bhkTwXqvby— Elizabeth Troutman Mitchell (@TheElizMitchell) December 9, 2025

EXCLUSIVE??: @DrMakaryFDA responded to a report saying he is delaying the review of the abortion pill.The FDA is currently in the “data acquisition phase” of the review," he told @DailySignal.“We do an ongoing review, but we’re also engaging in a robust study that can serve… pic.twitter.com/bhkTwXqvby

“The Biden FDA did not have a sufficient evidentiary basis to conclude that eliminating the in-person dispensing requirement was safe,” the brief says. “And because no in-person visit is required now, women cannot be meaningfully screened for serious contraindications for the use of this drug, such as ectopic pregnancy.”

“It also increases the likelihood that some women are being coerced into taking these drugs against their will, as the heartbreaking story of Plaintiff Rosalie Markezich illustrates,” the brief continues.

The amicus brief supports Murrill’s motion for preliminary relief and asks for a preliminary injunction ordering FDA to suspend or withdraw the 2023 Risk Evaluation and Mitigation Strategy while the case proceeds.  

Mifepristone has become the most common abortion method, accounting for about 63% of all abortions, according to the Guttmacher Institute, Planned Parenthood’s research arm. However, this is likely an undercount, according to the pro-life Charlotte Lozier Institute, because this count does not include abortions outside the formal health care system or under shield laws.

Shield laws allow abortionists to mail abortion drugs to women, including those in states that prohibit most abortions or impose gestational limits.

Murrill previously told The Daily Signal she is hopeful the judge will reject the Trump administration’s request to pause her lawsuit seeking to reinstate regulations of the abortion pill.

“I am certainly hopeful that he will not accept the Department of Justice’s position, because they haven’t given any concrete reason to believe they are actually moving forward,” she said.

The entry of abortion pills into Louisiana is dangerous, illegal, unethical. We’ve seen the harms that have come to women from the kind of unrestricted flooding of these pills into our states, and we’ve had numerous cases show up in emergency rooms. Louisiana will always protect… https://t.co/G3gKHb6Obb— Attorney General Liz Murrill (@AGLizMurrill) January 30, 2026

The entry of abortion pills into Louisiana is dangerous, illegal, unethical. We’ve seen the harms that have come to women from the kind of unrestricted flooding of these pills into our states, and we’ve had numerous cases show up in emergency rooms. Louisiana will always protect… https://t.co/G3gKHb6Obb

At the time, a spokesperson for the Justice Department told The Daily Signal in a statement that the agency “remains committed to advancing President Trump’s pro-life agenda, including through dismissing criminal prosecutions and civil lawsuits against peaceful pro-life advocates targeted by the previous administration, and using the FACE Act to protect pro-life pregnancy centers.”

“In this filing, the Department of Justice simply requested more time from the court for the FDA to complete its review of mifepristone REMS,” the spokesperson added. A Risk Evaluation and Mitigation Strategy, or REMS, is a protocol for the FDA to ensure safe usage of higher-risk drugs.

“As the Supreme Court recognized in a unanimous ruling less than two years ago,” the spokesperson continued, “it is the role of the FDA—not the federal courts—to evaluate drug safety data and impose appropriate precautions.”

Did Trump Admin Kill Red State’s Effort to Limit the Abortion Pill?

‘Why Is It Taking So Long?’ Senate Health Chair Urges Immediate FDA Action on Abortion Pill

EXCLUSIVE: Trump Moves to Claw Back Taxpayer Funds for Immigrant Children’s Abortions

Read the first chapter of The Woketopus right now for FREE

Today, even with President Trump’s victory, leftist elites have their tentacles in every aspect of our government.

The Daily Signal’s own Tyler O’Neil exposes this leftist cabal in his new book, The Woketopus: The Dark Money Cabal Manipulating the Federal Government.

In this book, O’Neil reveals how the Left’s NGO apparatus pursues its woke agenda, maneuvering like an octopus by circumventing Congress and entrenching its interests in the federal government.

You can read the first chapter of this new book for FREE in this eBook, The Woketopus: Chapter One using the secure link below.

The Tony Kinnett Cast

The Daily Signal Podcast

© 2025 The Daily Signal Media Group, Inc. All rights reserved.

We use cookies on our website. By using our website, you consent to cookies.  Learn More .  

© The Daily Signal